Longitudinal Endotyping Of Atopic Dermatitis Through Transcriptomic Skin Analysis
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Donald Leung, M.D., Ph.D.
National Jewish Health: Division of Pediatric Allergy and Clinical Immunology
Study Chair - Max A. Seibold, Ph.D.
National Jewish Health: Division of Pediatric Allergy and Clinical Immunology
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
10 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- University of California, San Diego: Dermatology Clinical Trials Unit
La Jolla, California, United States
- Children'S Hospital Los Angeles: Division of Clinical Immunology & Allergy
Los Angeles, California, United States
- National Jewish Health: Division of Pediatric Allergy and Clinical Immunology
Denver, Colorado, United States
- Boston Children'S Hospital: Department of Immunology
Boston, Massachusetts, United States
- Icahn School of Medicine at Mount Sinai: Department of Pediatrics Allergy & Immunology
New York, New York, United States
- University of Rochester Medical Center: Department of Dermatology
Rochester, New York, United States
- North Carolina Children'S Hospital: Department of Pediatrics, Division of Allergy, Immunology and Rheumatology
Chapel Hill, North Carolina, United States
- Cincinnati Children'S Hospital Medical Center: Asthma Center
Cincinnati, Ohio, United States
- Oregon Health & Science University: Department of Dermatology
Portland, Oregon, United States
- University of Pennsylvania, Perelman Center for Advanced Medicine: Department of Dermatology
Philadelphia, Pennsylvania, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 21 Nov 2022
- Primary completion
- 7 Apr 2025
- Completion
- 24 Oct 2025
- Last update posted
- 4 Jun 2026
- Registered enrollment
- 433
- Registry id
- NCT05436535
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.